molecules, nucleic acids, proteins, peptides, and other biologic payloads while aiming to reduce off-target exposure. Excellio Labs works on applications across oncology, neurodegenerative disease, cardiovascular disease, and regenerative medicine, enabling targeted delivery to previously hard-to-reach sites. Its platform is intended for use by biopharmaceutical and research partners developing advanced and personalized therapies.